Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 23:11:29.
doi: 10.1186/s13027-016-0076-7. eCollection 2016.

Systemic manifestations of hepatitis C infection

Lydia Tang  1 , Lauren Marcell  1 , Shyam Kottilil  1
Affiliations
Review

Systemic manifestations of hepatitis C infection

Lydia Tang et al. Infect Agent Cancer. .

Abstract

Chronic hepatitis C (HCV) is a common infection affecting 185 million people worldwide. The most common manifestation of chronic HCV is progressive liver fibrosis, cirrhosis, liver failure and hepatocellular carcinoma. However, several systemic manifestations of HCV have been recognized and reported in the literature. The purpose of this review is to assimilate published literature based on evidence to categorize these extrahepatic manifestations with the likelihood of a causal association with HCV. Exciting recent developments have resulted in simple all oral interferon-free highly effective therapy for HCV. However, this treatment is also expensive and less accessible to most affected individuals as treatment recommendations are based on stage of liver fibrosis. Expanding the scope of HCV therapy to those with extrahepatic manifestations beyond what is currently recommended will significantly reduce the morbidity and mortality in this aging population.

Keywords: Autoantibodies; Cryoglobulinemia; HCV; Lymphoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. von Hahn T, Rice CM. Hepatitis C virus entry. J Biol Chem. 2008;283:3689–93. doi: 10.1074/jbc.R700024200. - DOI - PubMed
    1. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312:631–40. doi: 10.1001/jama.2014.7085. - DOI - PubMed
    1. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42:2204–12. doi: 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D. - DOI - PubMed
    1. Lee MH, Yang HI, Lu SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206:469–77. doi: 10.1093/infdis/jis385. - DOI - PubMed
    1. Innes HA, McDonald SA, Dillon JF, et al. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology. 2015;62:355–64. doi: 10.1002/hep.27766. - DOI - PubMed